High Tide Inc.
$2.47
▲
1.76%
2026-04-21 07:18:00
www.hightideinc.com
NCM: HITI
Explore High Tide Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$288.3 M
Current Price
$2.47
52W High / Low
$5.59 / $2.85
Stock P/E
—
Book Value
$0.72
Dividend Yield
—
ROCE
6.2%
ROE
-39.72%
Face Value
—
EPS
$-0.42
Exp Qtr EPS
—
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
1,832
Beta
1.02
Debt / Equity
110.31
Current Ratio
1.43
Quick Ratio
0.7
Forward P/E
16.47
Price / Sales
0.33
Enterprise Value
$293.57 M
EV / EBITDA
10.1
EV / Revenue
0.47
Rating
Strong Buy
Target Price
$5.67
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Wellgistics Health, Inc. | $0.13 | — | $17.59 M | — | -11952.35% | 3545.19% | $7.04 / $0.1 | $-0.12 |
| 2. | Cellyan Biotechnology Co., Ltd | $0.73 | — | $8.03 M | — | 3.09% | -13.38% | $2.76 / $0.37 | $0.47 |
| 3. | Scienture Holdings, Inc. | $0.42 | — | $16.97 M | 12.89% | -19.95% | -55.65% | $2.6 / $0.24 | $1.73 |
| 4. | Ridgetech, Inc. | $2.21 | 0.16 | $2 M | — | -3.44% | -8.02% | $760.5 / $2.01 | $5.09 |
| 5. | Novartis AG | $147.76 | 20.66 | $301.93 B | 3.13% | 21.09% | 30.81% | $131 / $87.89 | $24.18 |
| 6. | Cboe Global Markets, Inc. | NOT FOUND | — | — | 0.96% | 21.81% | 23.36% | $309.87 / $207.75 | $49.1 |
| 7. | Adobe Inc. | $256.01 | 14.95 | $103.64 B | — | 45.12% | 58.77% | $422.95 / $224.13 | $28.16 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|
| Sales | 178.33 M | 164.03 M | 149.69 M | 137.8 M | 142.46 M | — | — |
| Operating Profit | 4.13 M | 6.12 M | 5.38 M | 2.38 M | 1.55 M | — | — |
| Net Profit | 1.21 M | -45.64 M | 0.6 M | -2.9 M | -2.81 M | — | — |
| EPS in Rs | 0.01 | -0.52 | 0.01 | -0.03 | -0.03 | -0.06 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 593.99 M | 522.31 M | 487.67 M | 356.85 M |
| Operating Profit | 15.44 M | 15.32 M | -2.66 M | -20.11 M |
| Net Profit | -50.75 M | -4.34 M | -39.31 M | -71.76 M |
| EPS in Rs | -0.58 | -0.05 | -0.45 | -0.82 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 349.06 M | 246.21 M | 233.4 M | 274.74 M |
| Total Liabilities | 246.28 M | 100.7 M | 99.73 M | 112.71 M |
| Equity | 87.61 M | 143.27 M | 131.56 M | 156.35 M |
| Current Assets | 136.88 M | 85.79 M | 68.64 M | 64.06 M |
| Current Liabilities | 99.92 M | 61.48 M | 58.14 M | 59.94 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 23.87 M | 35.55 M | 20.66 M | 4.5 M |
| Investing CF | -22.29 M | -11.01 M | -5.72 M | -8.59 M |
| Financing CF | 0.2 M | -7.72 M | -9.26 M | 15.17 M |
| Free CF | 13.22 M | 25.8 M | 14.58 M | -4.56 M |
| Capex | -10.65 M | -9.75 M | -6.08 M | -9.05 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 7.1% | 36.66% | — | — |
| Earnings Growth % | 88.97% | 45.22% | — | — |
| Profit Margin % | -0.83% | -8.06% | -20.11% | — |
| Operating Margin % | 2.93% | -0.55% | -5.64% | — |
| Gross Margin % | 27.28% | 26.93% | 28.29% | — |
| EBITDA Margin % | 6.47% | -0.86% | -9.43% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2021-05-13 | 1:0.0666667 |